Neuropace, Inc. Common Stock Share Price
NASDAQ: NPCEHealthcare
Live Neuropace, Inc. Common Stock Share Price Chart
O H L
Neuropace, Inc. Common Stock Performance Overview
Days Range
▼
$14.25Low
$14.25High
Markets Today
| Previous Close | $14.15 |
|---|---|
| Open | $14.25 |
| Volume | 39,119 |
| Day's Range | $14.25 - $14.25 |
| 52W Range | $9.22 - $19.60 |
| Market Cap | $483.97 M |
Historical Performance
| 1M Returns | -2.21 |
|---|---|
| 3M Returns | -9.47 |
| 6M Returns | +4.35 |
| 1Y Returns | +37.11 |
| 5Y Returns | -18.77 |
| 10Y Returns | NA |
Neuropace, Inc. Common Stock Fundamentals
| Market Cap | $483.97 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $99.99 M |
| ROE TTM | -1.59 |
| EPS TTM | $-0.57 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 40.68 |
| EBITDA | $-16.10 M |
| Profit Margin | -21.47 |
| Market Cap | $483.97 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $99.99 M |
| ROE TTM | -1.59 |
| EPS TTM | $-0.57 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 40.68 |
| EBITDA | $-16.10 M |
| Profit Margin | -21.47 |
Neuropace, Inc. Common Stock Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $22.52 M | $19.50 M | $27.35 M | $26.59 M | $22.07 M | $22.83 M |
| Gross Profit + | $17.34 M | $16.21 M | $21.17 M | $20.58 M | $18.05 M | $18.91 M |
| Operating Income | -$5.15 M | -$8.19 M | -$2.60 M | -$1.77 M | -$5.57 M | -$5.14 M |
| EBITDA | -$5.10 M | -$8.13 M | -$2.55 M | -$1.69 M | -$5.51 M | -$5.08 M |
| Interest Expense | -$2.15 M | -$2.06 M | -$1.65 M | -$1.60 M | -$1.52 M | -$1.54 M |
| Depreciation | $49.00 K | $55.00 K | $54.00 K | $80.00 K | $60.00 K | $66.00 K |
| Income Before Tax | -$6.59 M | -$10.02 M | -$3.50 M | -$2.73 M | -$6.69 M | -$6.20 M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income + | -$6.59 M | -$8.65 M | -$3.50 M | -$2.73 M | -$6.69 M | -$6.20 M |
| Net Profit Margin | -29.25% | -44.36% | -12.78% | -10.26% | -30.31% | -27.16% |
Neuropace, Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $33.00 K | $33.00 K | $33.00 K | $34.00 K | $34.00 K | $34.00 K |
| Reserve & Surplus | -$537.54 M | -$546.19 M | -$549.69 M | -$552.41 M | -$559.10 M | -$565.30 M |
| Non-Current Liabilities | $71.23 M | $69.53 M | $69.13 M | $68.72 M | $68.28 M | $67.67 M |
| Current Liabilities | $14.71 M | $17.14 M | $19.61 M | $17.22 M | $16.17 M | $17.43 M |
| Total Liabilities | $85.94 M | $86.68 M | $88.74 M | $86.53 M | $84.44 M | $85.11 M |
| Fixed Assets | $1.16 M | $1.16 M | $1.11 M | $1.13 M | $1.28 M | $1.24 M |
| Current Assets | $97.48 M | $93.74 M | $95.33 M | $94.07 M | $86.98 M | $86.19 M |
| Total Assets | $110.20 M | $106.11 M | $107.25 M | $105.56 M | $98.90 M | $96.99 M |
Neuropace, Inc. Common Stock Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$6.59 M | -$8.65 M | -$3.50 M | -$2.73 M | -$6.69 M | -$6.20 M |
| Operating Cash Flow | -$7.48 M | -$2.09 M | -$1.94 M | $506.00 K | -$5.90 M | -$3.90 M |
| Investing Cash Flow | -$37.00 K | -$168.00 K | -$30.00 K | -$97.00 K | -$117.00 K | -$125.00 K |
| Financing Cash Flow | $21.11 M | -$1.91 M | -$235.00 K | $635.00 K | -$166.00 K | $1.18 M |
| Change in Cash | $13.59 M | -$4.16 M | -$2.21 M | $1.04 M | -$6.18 M | -$2.85 M |
Neuropace, Inc. Common Stock Return Calculator
The Neuropace, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$8,071
Invested Amount$10,000
Est. Returns$-1,929
About Neuropace, Inc. Common Stock
NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.
Popular Stocks
FAQs
What is the share price of Neuropace, Inc. Common Stock today?
Neuropace, Inc. Common Stock (NPCE) share price as of September 18, 2026 is $14.06. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Neuropace, Inc. Common Stock?
Yes, Indian Investors can invest in the Neuropace, Inc. Common Stock (NPCE) Share by opening an international trading account with Angel One.
How can I purchase Neuropace, Inc. Common Stock shares in India?
Purchasing Neuropace, Inc. Common Stock (NPCE) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Neuropace, Inc. Common Stock (NPCE) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Neuropace, Inc. Common Stock?
Yes, you can purchase fractional shares of Neuropace, Inc. Common Stock (NPCE) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Neuropace, Inc. Common Stock?
The market capitalization of Neuropace, Inc. Common Stock on September 18, 2026, is $483.97 M.
In which sector Neuropace, Inc. Common Stock belongs?
Neuropace, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Neuropace, Inc. Common Stock stocks?
In order to invest in Neuropace, Inc. Common Stock (NPCE) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
